Condensed Consolidated Statements of Stockholders’ Equity - USD ($) shares in Thousands, $ in Thousands	Total	Restricted Stock Units	Cumulative-effect adjustment from adoption of ASU 2020-06	Common Stock	Common Stock Restricted Stock Units	Additional Paid-in Capital	Additional Paid-in Capital Restricted Stock Units	Additional Paid-in Capital Cumulative-effect adjustment from adoption of ASU 2020-06	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss Cumulative-effect adjustment from adoption of ASU 2020-06	Accumulated Deficit
Beginning balance (in shares) at Feb. 06, 2022				292,633
Beginning balance at Feb. 06, 2022	$ 754,336		$ (35,127)	$ 29		$ 2,470,943		$ (133,265)	$ (8,365)	$ 98,138	$ (1,708,271)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				2,316
Issuance of common stock upon exercise of stock options	19,139					19,139
Stock-based compensation expense	246,677					246,677
Vesting of restricted stock units (in shares)					10,632
Vesting of restricted stock units		$ 0			$ 1		$ (1)
Tax withholding on vesting of equity awards and restricted stock units (in shares)					(517)
Tax withholding on vesting of equity awards and restricted stock units		(16,130)					(16,130)
Common stock issued under employee stock purchase plan (in shares)				3,014
Common stock issued under employee stock purchase plan	39,965					39,965
Repurchases of common stock (in shares)				(5,409)
Repurchases of common stock	(151,564)					(151,564)
Other comprehensive (loss) income	(15,388)								(15,388)
Net income (loss)	(1,400)										(1,400)
Ending balance (in shares) at Nov. 06, 2022				302,669
Ending balance at Nov. 06, 2022	840,508			$ 30		2,475,764			(23,753)		(1,611,533)
Beginning balance (in shares) at Aug. 07, 2022				298,801
Beginning balance at Aug. 07, 2022	761,358			$ 30		2,392,173			(20,099)		(1,610,746)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				459
Issuance of common stock upon exercise of stock options	3,878					3,878
Stock-based compensation expense	86,852					86,852
Vesting of restricted stock units (in shares)					3,482
Tax withholding on vesting of equity awards and restricted stock units (in shares)					(112)
Tax withholding on vesting of equity awards and restricted stock units		(3,143)					(3,143)
Common stock issued under employee stock purchase plan (in shares)				927
Common stock issued under employee stock purchase plan	20,569					20,569
Repurchases of common stock (in shares)				(888)
Repurchases of common stock	(24,565)					(24,565)
Other comprehensive (loss) income	(3,654)								(3,654)
Net income (loss)	(787)										(787)
Ending balance (in shares) at Nov. 06, 2022				302,669
Ending balance at Nov. 06, 2022	840,508			$ 30		2,475,764			(23,753)		(1,611,533)
Beginning balance (in shares) at Feb. 05, 2023				304,076
Beginning balance at Feb. 05, 2023	941,233			$ 30		2,493,769			(15,504)		(1,537,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				3,711
Issuance of common stock upon exercise of stock options	32,878					32,878
Stock-based compensation expense	259,189					259,189
Vesting of restricted stock units (in shares)					10,613
Vesting of restricted stock units		0			$ 2		(2)
Tax withholding on vesting of equity awards and restricted stock units (in shares)					(546)
Tax withholding on vesting of equity awards and restricted stock units		(16,582)					(16,582)
Common stock issued under employee stock purchase plan (in shares)				2,233
Common stock issued under employee stock purchase plan	45,089					45,089
Repurchases of common stock (in shares)				(4,102)
Repurchases of common stock	(114,341)					(114,341)
Issuance of common stock upon conversion of convertible senior notes (in shares)				1
Issuance of common stock upon conversion of convertible senior notes	(356)					(356)
Other comprehensive (loss) income	5,472								5,472
Net income (loss)	(4,127)										(4,127)
Ending balance (in shares) at Nov. 05, 2023				315,986
Ending balance at Nov. 05, 2023	1,148,455			$ 32		2,699,644			(10,032)		(1,541,189)
Beginning balance (in shares) at Aug. 06, 2023				311,839
Beginning balance at Aug. 06, 2023	986,328			$ 31		2,610,482			(12,607)		(1,611,578)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				311
Issuance of common stock upon exercise of stock options	2,996					2,996
Stock-based compensation expense	89,512					89,512
Vesting of restricted stock units (in shares)					3,438
Vesting of restricted stock units		0			$ 1	(1)
Tax withholding on vesting of equity awards and restricted stock units (in shares)					(131)
Tax withholding on vesting of equity awards and restricted stock units		$ (4,755)					$ (4,755)
Common stock issued under employee stock purchase plan (in shares)				1,164
Common stock issued under employee stock purchase plan	23,870					23,870
Repurchases of common stock (in shares)				(635)
Repurchases of common stock	(22,460)					(22,460)
Other comprehensive (loss) income	2,575								2,575
Net income (loss)	70,389										70,389
Ending balance (in shares) at Nov. 05, 2023				315,986
Ending balance at Nov. 05, 2023	$ 1,148,455			$ 32		$ 2,699,644			$ (10,032)		$ (1,541,189)